Post-Doctoral Research Fellow - Gene Editing Therapy
 Massachusetts Eye and Ear Infirmary - MEI | |
 United States, Massachusetts, Boston | |
| 243-245 Charles Street (Show on map) | |
 Feb 13, 2026 | |
|
Company Description
Massachusetts Eye and Ear is a world-renowned specialty hospital focused on treating disorders of the eye, ear, nose, throat, and head and neck regions. Affiliated with Harvard Medical School, the institution is a leader in patient care, education, and research in its areas of expertise. Beyond offering advanced medical and surgical services, Mass Eye and Ear conducts cutting-edge laboratory and clinical research to improve care for current and future patients. Serving locally and globally, the hospital is committed to improving lives through innovative treatments and academic excellence in healthcare. We are seeking postdoctoral fellows to work on gene and editing therapy for genetic hearing loss and advancing our findings toward clinical applications. Our gene and editing therapies have successfully restored hearing in multiple mouse models (Gao et al., Nature, 2017; Du et al., Mol Ther, 2023; Yong et al., Nat Commun, 2023; Zhu et al., Sci Transl Med, 2024; Wei et al., JCI, 2025). The projects include the development of new technologies (e.g. RNA editing, epigenetic modifications, shRNA) for different forms of genetic hearing loss and multiple IND-enabling studies for gene and editing therapies with the goals to initiate clinical trials in 3 years. The work is supported by the NIH SCGE program (https://scge.mcw.edu/ind-enabling-studies-multiple-disease-platforms/). Our laboratory employs state-of-the-art technologies, including in vitro adult cochlea explant culture, reprogramming, scRNAseq, inner ear organoids, genome editing, gene therapy, viral and non-viral delivery, and physiological function analysis. We are collaborating with the industry, working with CROs and interacting with the FDA to bring our work towards the clinic. We are pioneers in clinical translational applications, having conducted the first successful OTOF gene therapy trial in children born with complete hearing loss, resulting in restored hearing and speech capabilities (Lv et al., The Lancet, 2024; Wang et al., Nat Med, 2024). Our lab is part of Eaton-Peabody Laboratories, the largest hearing research center globally, renowned for its diverse research programs in hearing science. We offer a unique and exciting opportunity for candidates interested in advancing basic research to translational applications, including human studies. Candidate Requirements: We seek individuals with a Ph.D., M.D./Ph.D., or M.D. For gene/editing therapy, we seek candidates with a strong background in genetic hearing loss, in vivo animal inner ear study, AAV-mediated gene therapy and editing technology. A strong track record of scientific publications is essential. Please email a curriculum vita, a description of research accomplishments and names of three references to: Zheng-Yi Chen (617-909-6090) Associate Professor Massachusetts Eye & Ear/Harvard Medical School Boston, MA 02114 Zheng-Yi_Chen@meei.harvard.edu Massachusetts Eye and Ear Infirmary is an Equal Opportunity Employer. By embracing diverse skills, perspectives and ideas, we choose to lead. All qualified applicants will receive consideration for employment without regard to race, color, religious creed, national origin, sex, age, gender identity, disability, sexual orientation, military service, genetic information, and/or other status protected under law. We will ensure that all individuals with a disability are provided a reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. | |